Picture of Surrozen logo

SRZN — Surrozen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Surrozen Inc reports results for the quarter ended in June - Earnings Summary

* Surrozen Inc  SRZN.OQ  reported a quarterly adjusted loss
of
$1.54​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of
$-4.65.  The mean expectation of two analysts for the quarter
was for a loss of $2.79 per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * Surrozen Inc's reported EPS for the quarter was a loss of
$7.99​.
    * The company reported a quarterly loss of $25.26 million.
    * Surrozen Inc shares had fallen by 34.2% this quarter and
lost 23.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Surrozen Inc is
$33.00 
This summary was machine generated from LSEG data August 16 at
12:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -2.79          -1.54          Beat
 Mar. 31 2024      -4.25          -4.24          Beat
 Dec. 31 2023      -3.00          -4.41          Missed
 Sep. 30 2023      -4.42          -5.10          Missed

Recent news on Surrozen

See all news